Cargando…
Allopregnanolone in postpartum depression: Role in pathophysiology and treatment
Postpartum depression (PPD) is a unique subtype of major depressive disorder and a substantial contributor to maternal morbidity and mortality. In addition to affecting the mother, PPD can have short- and long-term consequences for the infant and partner. The precise etiology of PPD is unknown, but...
Autores principales: | Meltzer-Brody, Samantha, Kanes, Stephen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7231991/ https://www.ncbi.nlm.nih.gov/pubmed/32435663 http://dx.doi.org/10.1016/j.ynstr.2020.100212 |
Ejemplares similares
-
Allopregnanolone-based treatments for postpartum depression: Why/how do they work?
por: Walton, Najah, et al.
Publicado: (2019) -
Allopregnanolone: From molecular pathophysiology to therapeutics. A historical perspective
por: Paul, Steven M, et al.
Publicado: (2020) -
The role of allopregnanolone in depressive-like behaviors: Focus on neurotrophic proteins
por: Almeida, Felipe Borges, et al.
Publicado: (2020) -
Early postnatal allopregnanolone levels alteration and adult behavioral disruption in rats: Implication for drug abuse
por: Bartolomé, Iris, et al.
Publicado: (2019) -
Pregnane steroidogenesis is altered by HIV-1 Tat and morphine: Physiological allopregnanolone is protective against neurotoxic and psychomotor effects
por: Paris, Jason J., et al.
Publicado: (2020)